Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 32 | 2023 | 11124 | 1.820 |
Why?
|
| Oncogene Proteins, Fusion | 9 | 2023 | 1581 | 1.260 |
Why?
|
| Carcinoma, Renal Cell | 6 | 2023 | 3143 | 0.950 |
Why?
|
| Serine Endopeptidases | 7 | 2023 | 1072 | 0.890 |
Why?
|
| Kidney Neoplasms | 5 | 2023 | 4262 | 0.800 |
Why?
|
| Trans-Activators | 4 | 2016 | 2924 | 0.660 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 468 | 0.660 |
Why?
|
| Antioxidants | 2 | 2017 | 1663 | 0.640 |
Why?
|
| Acrylamide | 1 | 2018 | 60 | 0.630 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2022 | 17446 | 0.590 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2019 | 1142 | 0.540 |
Why?
|
| Nonsteroidal Anti-Androgens | 1 | 2015 | 8 | 0.530 |
Why?
|
| Diet Surveys | 1 | 2018 | 1173 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 11725 | 0.460 |
Why?
|
| Diet | 8 | 2023 | 7939 | 0.440 |
Why?
|
| Carotenoids | 1 | 2016 | 624 | 0.430 |
Why?
|
| Breast Neoplasms | 7 | 2023 | 20822 | 0.410 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 712 | 0.410 |
Why?
|
| Family Health | 1 | 2017 | 1282 | 0.400 |
Why?
|
| Risk Factors | 25 | 2023 | 72290 | 0.400 |
Why?
|
| Ferritins | 1 | 2014 | 590 | 0.390 |
Why?
|
| Twins, Dizygotic | 3 | 2017 | 236 | 0.380 |
Why?
|
| Follow-Up Studies | 17 | 2023 | 39050 | 0.370 |
Why?
|
| Twins, Monozygotic | 3 | 2017 | 458 | 0.350 |
Why?
|
| Prospective Studies | 18 | 2023 | 53288 | 0.350 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3336 | 0.330 |
Why?
|
| Dementia | 4 | 2023 | 2518 | 0.320 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 1206 | 0.300 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2014 | 1366 | 0.300 |
Why?
|
| Neoplasms | 10 | 2023 | 21683 | 0.250 |
Why?
|
| Male | 49 | 2023 | 350118 | 0.250 |
Why?
|
| Incidence | 10 | 2023 | 20947 | 0.250 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2541 | 0.250 |
Why?
|
| Middle Aged | 32 | 2023 | 213383 | 0.240 |
Why?
|
| Proportional Hazards Models | 9 | 2023 | 12354 | 0.230 |
Why?
|
| Multifactorial Inheritance | 2 | 2020 | 1194 | 0.220 |
Why?
|
| Humans | 63 | 2023 | 744343 | 0.220 |
Why?
|
| Genome-Wide Association Study | 11 | 2021 | 12261 | 0.220 |
Why?
|
| Aged | 29 | 2023 | 163280 | 0.210 |
Why?
|
| Lung Neoplasms | 3 | 2022 | 13102 | 0.210 |
Why?
|
| Dementia, Vascular | 1 | 2023 | 128 | 0.210 |
Why?
|
| Obesity | 4 | 2023 | 12745 | 0.210 |
Why?
|
| Alzheimer Disease | 4 | 2023 | 8037 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 12 | 2020 | 15519 | 0.190 |
Why?
|
| Membrane Proteins | 2 | 2017 | 7880 | 0.190 |
Why?
|
| Genetic Pleiotropy | 2 | 2020 | 182 | 0.180 |
Why?
|
| Prostate-Specific Antigen | 3 | 2023 | 2494 | 0.180 |
Why?
|
| Tea | 1 | 2021 | 275 | 0.170 |
Why?
|
| Hyperinsulinism | 1 | 2022 | 415 | 0.170 |
Why?
|
| Receptors, Somatomedin | 1 | 2018 | 57 | 0.170 |
Why?
|
| Prostate | 3 | 2023 | 1774 | 0.170 |
Why?
|
| Case-Control Studies | 8 | 2020 | 21746 | 0.170 |
Why?
|
| Cohort Studies | 8 | 2023 | 40561 | 0.170 |
Why?
|
| Spouses | 1 | 2021 | 286 | 0.160 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2022 | 604 | 0.160 |
Why?
|
| Adult | 19 | 2023 | 214055 | 0.160 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 6773 | 0.160 |
Why?
|
| Body Mass Index | 5 | 2023 | 12720 | 0.140 |
Why?
|
| Immunohistochemistry | 5 | 2018 | 11366 | 0.140 |
Why?
|
| Coffee | 1 | 2021 | 578 | 0.140 |
Why?
|
| Alopecia | 1 | 2020 | 382 | 0.140 |
Why?
|
| Risk Assessment | 7 | 2020 | 23338 | 0.130 |
Why?
|
| Exercise | 3 | 2023 | 5615 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1038 | 0.130 |
Why?
|
| Female | 22 | 2023 | 380194 | 0.130 |
Why?
|
| Individuality | 1 | 2017 | 307 | 0.130 |
Why?
|
| Receptor, Insulin | 1 | 2018 | 846 | 0.120 |
Why?
|
| Secondary Prevention | 1 | 2021 | 1530 | 0.120 |
Why?
|
| Health Behavior | 2 | 2023 | 2636 | 0.120 |
Why?
|
| GTPase-Activating Proteins | 1 | 2017 | 498 | 0.120 |
Why?
|
| Logistic Models | 2 | 2021 | 13408 | 0.120 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 1788 | 0.110 |
Why?
|
| Life Style | 2 | 2022 | 3835 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2016 | 471 | 0.110 |
Why?
|
| Research Design | 2 | 2020 | 5987 | 0.100 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2015 | 415 | 0.100 |
Why?
|
| Quantitative Trait Loci | 2 | 2017 | 2019 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 624 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 2133 | 0.100 |
Why?
|
| Odds Ratio | 4 | 2020 | 9849 | 0.100 |
Why?
|
| Gene Frequency | 2 | 2017 | 3588 | 0.100 |
Why?
|
| Memory | 1 | 2021 | 2174 | 0.100 |
Why?
|
| Body Height | 1 | 2017 | 1577 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 2015 | 0.090 |
Why?
|
| Meat | 1 | 2014 | 592 | 0.090 |
Why?
|
| Prostatectomy | 2 | 2023 | 1890 | 0.090 |
Why?
|
| Congenital Abnormalities | 1 | 2015 | 707 | 0.090 |
Why?
|
| Europe | 1 | 2017 | 3339 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2023 | 9239 | 0.090 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 57776 | 0.090 |
Why?
|
| Linkage Disequilibrium | 1 | 2015 | 1997 | 0.090 |
Why?
|
| Models, Statistical | 2 | 2015 | 5102 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 8428 | 0.090 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 1058 | 0.090 |
Why?
|
| Premenopause | 1 | 2014 | 1033 | 0.090 |
Why?
|
| Gene Fusion | 1 | 2012 | 371 | 0.080 |
Why?
|
| Breast | 2 | 2017 | 1969 | 0.080 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 3086 | 0.080 |
Why?
|
| Genotype | 2 | 2021 | 12951 | 0.080 |
Why?
|
| Estradiol | 1 | 2016 | 2020 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2282 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3255 | 0.080 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 1912 | 0.080 |
Why?
|
| Cognition Disorders | 1 | 2022 | 4043 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2020 | 2303 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2017 | 2575 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2020 | 6196 | 0.070 |
Why?
|
| Body Weight | 1 | 2017 | 4669 | 0.070 |
Why?
|
| Risk | 2 | 2016 | 9687 | 0.070 |
Why?
|
| Aspirin | 1 | 2018 | 3282 | 0.070 |
Why?
|
| Testosterone | 1 | 2016 | 2420 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2849 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2021 | 4445 | 0.060 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2020 | 967 | 0.060 |
Why?
|
| Prognosis | 4 | 2018 | 29063 | 0.060 |
Why?
|
| Smoking | 1 | 2021 | 8987 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2017 | 5021 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2016 | 3188 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10180 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 4328 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2017 | 12026 | 0.050 |
Why?
|
| Mass Screening | 1 | 2018 | 5255 | 0.050 |
Why?
|
| Disease Progression | 4 | 2021 | 13284 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2015 | 10252 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2023 | 318 | 0.050 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2021 | 74 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 9856 | 0.050 |
Why?
|
| Delayed Diagnosis | 1 | 2022 | 441 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2022 | 8324 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2023 | 711 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2021 | 544 | 0.040 |
Why?
|
| Phenotype | 3 | 2022 | 16365 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 706 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 15165 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2020 | 925 | 0.040 |
Why?
|
| Genes, BRCA1 | 1 | 2021 | 781 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 11031 | 0.040 |
Why?
|
| Wnt Proteins | 1 | 2021 | 721 | 0.040 |
Why?
|
| Mammography | 2 | 2020 | 2476 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2018 | 390 | 0.030 |
Why?
|
| Insulin | 2 | 2022 | 6580 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2023 | 1184 | 0.030 |
Why?
|
| beta Catenin | 1 | 2021 | 1059 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 1616 | 0.030 |
Why?
|
| Androgens | 1 | 2023 | 1281 | 0.030 |
Why?
|
| Young Adult | 2 | 2023 | 56430 | 0.030 |
Why?
|
| Educational Status | 1 | 2023 | 2540 | 0.030 |
Why?
|
| United States | 4 | 2018 | 69872 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 35136 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 1743 | 0.030 |
Why?
|
| Alleles | 2 | 2017 | 6933 | 0.030 |
Why?
|
| Norway | 1 | 2016 | 448 | 0.030 |
Why?
|
| Finland | 1 | 2016 | 602 | 0.030 |
Why?
|
| Aging | 2 | 2023 | 8664 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2023 | 1377 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 1660 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 41006 | 0.030 |
Why?
|
| Endonucleases | 1 | 2017 | 380 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2015 | 279 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1783 | 0.030 |
Why?
|
| Denmark | 1 | 2016 | 738 | 0.030 |
Why?
|
| Weight Gain | 1 | 2023 | 2292 | 0.030 |
Why?
|
| Executive Function | 1 | 2022 | 1364 | 0.030 |
Why?
|
| Adolescent | 2 | 2022 | 85781 | 0.030 |
Why?
|
| Sweden | 1 | 2016 | 1345 | 0.030 |
Why?
|
| Overweight | 1 | 2023 | 2371 | 0.030 |
Why?
|
| Genomics | 2 | 2020 | 5720 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5078 | 0.020 |
Why?
|
| Survivors | 1 | 2022 | 2291 | 0.020 |
Why?
|
| Biopsy | 1 | 2023 | 6756 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4851 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2013 | 917 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 6993 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2021 | 2071 | 0.020 |
Why?
|
| Child | 1 | 2017 | 77709 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3297 | 0.020 |
Why?
|
| Age Factors | 2 | 2015 | 18370 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 7913 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 4644 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 13989 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 1179 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 19905 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2021 | 23403 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 9438 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12245 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 9959 | 0.020 |
Why?
|
| Postmenopause | 1 | 2014 | 2461 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6538 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 4217 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 7799 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15226 | 0.010 |
Why?
|
| Time Factors | 2 | 2016 | 40075 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10481 | 0.010 |
Why?
|
| Inflammation | 1 | 2022 | 10638 | 0.010 |
Why?
|
| Apoptosis | 1 | 2018 | 9727 | 0.010 |
Why?
|
| Health Personnel | 1 | 2015 | 3218 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5686 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 25043 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 12804 | 0.010 |
Why?
|
| Registries | 1 | 2014 | 8089 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15076 | 0.010 |
Why?
|
| Physicians | 1 | 2015 | 4567 | 0.010 |
Why?
|
| Brain | 1 | 2023 | 26385 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 35421 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 63114 | 0.000 |
Why?
|
Concepts
(205)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_